Announcement

Collapse
No announcement yet.

Clinical Trial for DIPG and recurrent neuroblastoma using an innovative combination of molecular-guided therapy and personalized immunotherapy

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Clinical Trial for DIPG and recurrent neuroblastoma using an innovative combination of molecular-guided therapy and personalized immunotherapy

    For patients 30 and younger, study between University of Florida and Wake Forest/Carolina Medical.


    Going to test a specifically tailored drug treatment, a cancer vaccine containing dendritic cells and adoptive T cell therapy. Seems like three different treatments in one trial.








    https://mbi.ufl.edu/2021/09/29/new-p...y-combination/
    Last edited by davidfinn; 10-04-2021, 01:44 PM.

  • #2
    I love approaches like this. No one treatment is going to be the cure. This is how treatments for all brain tumors should be approached nationwide.

    Comment

    Working...
    X